SERVIER PHARMA - Company finances
|
EUR
|
2018
From: 2017-10-01
To: 2018-09-30
|
2019
From: 2018-10-01
To: 2019-09-30
|
2020
From: 2019-10-01
To: 2020-09-30
|
2021
From: 2020-10-01
To: 2021-09-30
|
2022
From: 2021-10-01
To: 2022-09-30
|
2023
From: 2022-10-01
To: 2023-09-30
|
2024
From: 2023-10-01
To: 2024-09-30
|
2025
From: 2024-10-01
To: 2025-09-30
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 32,566,046 | 34,186,496 | 36,870,450 | 39,345,838 | 46,959,816 | 53,115,469 | 59,685,171 | 62,467,589 |
| Profit before tax | 1,129,899 | 1,004,043 | 906,835 | 1,845,936 | 3,532,513 | 5,923,179 | 6,951,938 | 7,496,173 |
| Net profit | 938,920 | 844,999 | 750,088 | 1,389,721 | 2,868,434 | 4,898,661 | 5,806,634 | 6,298,774 |
| Equity | 4,318,636 | 3,663,635 | 4,413,723 | 5,803,444 | 6,171,878 | 7,570,539 | 8,377,173 | 7,675,947 |
| Liabilities | 2,630,369 | 5,251,039 | 11,481,919 | 5,287,122 | 5,191,560 | 6,052,326 | 3,435,982 | 1,825,619 |
| Non-current assets | 113,554 | 1,111,541 | 1,799,886 | 1,440,368 | 1,087,702 | 694,619 | 393,949 | 152,941 |
| Current assets | 7,133,491 | 8,703,757 | 14,915,334 | 10,631,124 | 11,355,231 | 14,193,880 | 13,227,612 | 9,967,611 |
| Total assets | 7,247,045 | 9,815,298 | 16,715,220 | 12,071,492 | 12,442,933 | 14,888,499 | 13,621,561 | 10,120,552 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 3,366,498 | 3,874,512 | 4,177,457 |
| Social insurance contributions | - | - | - | - | - | 581,788 | 578,725 | 606,071 |
|
Financial indicators
|
||||||||
| Revenue change y/y | -13.6% | +5.0% | +7.9% | +6.7% | +19.4% | +13.1% | +12.4% | +4.7% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 13.0% | 8.6% | 4.5% | 11.5% | 23.1% | 32.9% | 42.6% | 62.2% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 21.7% | 23.1% | 17.0% | 23.9% | 46.5% | 64.7% | 69.3% | 82.1% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 2.9% | 2.5% | 2.0% | 3.5% | 6.1% | 9.2% | 9.7% | 10.1% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 3.5% | 2.9% | 2.5% | 4.7% | 7.5% | 11.2% | 11.6% | 12.0% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.6 | 1.4 | 2.6 | 0.9 | 0.8 | 0.8 | 0.4 | 0.2 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 685,601 | 775,498 | 842,753 | 879,237 | 1,069,293 | 1,189,151 | 1,429,585 | 1,464,083 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
SERVIER PHARMA - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2025-11-18 | 2025-11-18 | 6.12 |
SERVIER PHARMA - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-08-03 | 2026-08-03 | 682.24 |
| 2025-06-20 | 2025-06-20 | 853.84 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
SERVIER PHARMA, UAB (code 300088003) is a Private Limited Liability Company operating in the wholesale of pharmaceutical and medical goods. In 2025, the company generated revenue of €62.47M, up 4.7% year on year and 17.6% over two years. Net profit reached €6.30M, compared with €5.81M in 2024 and €4.90M in 2023, while the profit margin improved from 9.2% in 2023 to 9.7% in 2024 and 10.1% in 2025. The balance sheet total decreased to €10.12M in 2025 from €13.62M a year earlier and €14.89M in 2023. Equity stood at €7.68M and liabilities at €1.83M, indicating a lower debt load than in prior years, when liabilities were €3.44M in 2024 and €6.05M in 2023. Key 2025 ratios were ROE of 82.1%, ROA of 62.2%, debt-to-equity of 0.24, and asset turnover of 6.17x. Revenue per employee was €1.49M and profit per employee €150.0K.